Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carducci

Showing results (311-320 of 386) with videos related to

Pageof 39
Sort By:
Journal of Cancer Survivorship : Research and Practice|December 8, 2023
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patientsKala Visvanathan, Dana Petry, Michelle S McCullough, et al.
Investigational New Drugs|May 3, 2014
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patientsAnna Spreafico, Kim N Chi, Srikala S Sridhar, et al.
European Urology|March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell CarcinomaAndres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicityCharles M Rudin, Wanqing Liu, Apurva Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and gliomaJordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Molecular Oncology|September 10, 2022
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancerYuki Yoshikawa, Konrad H Stopsack, Xin Victoria Wang, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|September 15, 2016
Are 6-8 year old Italian children moving away from the Mediterranean diet?C Zani, E Ceretti, S Grioni, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomyA J Armstrong, S Halabi, P Healy, et al.
The Journal of Clinical Endocrinology and Metabolism|April 22, 2021
Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized TrialHsin-Chieh Yeh, Nisa M Maruthur, Nae-Yuh Wang, et al.
BMJ Open|September 18, 2014
Monitoring air pollution effects on children for supporting public health policy: the protocol of the prospective cohort MAPEC studyD Feretti, E Ceretti, A De Donno, et al.
Pageof 39

Showing results (311-320 of 386) with videos related to

Sort By:
Pageof 39
Journal of Cancer Survivorship : Research and Practice|December 8, 2023
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patientsKala Visvanathan, Dana Petry, Michelle S McCullough, et al.
Investigational New Drugs|May 3, 2014
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patientsAnna Spreafico, Kim N Chi, Srikala S Sridhar, et al.
European Urology|March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell CarcinomaAndres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicityCharles M Rudin, Wanqing Liu, Apurva Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and gliomaJordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Molecular Oncology|September 10, 2022
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancerYuki Yoshikawa, Konrad H Stopsack, Xin Victoria Wang, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|September 15, 2016
Are 6-8 year old Italian children moving away from the Mediterranean diet?C Zani, E Ceretti, S Grioni, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomyA J Armstrong, S Halabi, P Healy, et al.
The Journal of Clinical Endocrinology and Metabolism|April 22, 2021
Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized TrialHsin-Chieh Yeh, Nisa M Maruthur, Nae-Yuh Wang, et al.
BMJ Open|September 18, 2014
Monitoring air pollution effects on children for supporting public health policy: the protocol of the prospective cohort MAPEC studyD Feretti, E Ceretti, A De Donno, et al.
Pageof 39